Planta Med 2017; 83(12/13): 1053-1057
DOI: 10.1055/s-0043-100632
Natural Product Chemistry and Analytical Studies
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Quantitative Determination of Lactones in Piper methysticum (Kava-Kava) by Supercritical Fluid Chromatography[*]

Adele Murauer
Institute of Pharmacy, Pharmacognosy, University of Innsbruck, Innsbruck, Austria
,
Markus Ganzera
Institute of Pharmacy, Pharmacognosy, University of Innsbruck, Innsbruck, Austria
› Author Affiliations
Further Information

Publication History

received 29 November 2016
revised 20 December 2016

accepted 09 January 2017

Publication Date:
17 January 2017 (online)

Abstract

A fast and validated supercritical fluid chromatography method for the quantitative determination of major lactones in Piper methysticum, a plant used against nervous anxiety, stress, and restlessness, was developed. The baseline separation of dihydrokavain, demethoxyyangonin, kavain, yangonin, dihydromethysticin, and methysticin was possible in less than 4 min on an Aquity UPC2 BEH 1.7 µm column, in combination with a mobile phase comprising CO2 and methanol with diethylamine. The column temperature had a great impact on the results because only at 70 °C could kavain and yangonin be fully resolved. With correlation coefficients above 0.998, recovery rates between 95.9 and 104.1 % as well as limit of detection values below 1.5 ng on-column, the procedure fulfilled all validation requirements and was well suited for the quantitative analysis of commercial products containing P. methysticum root powder and/or extract. All of them contained the target analytes, however, the absolute content of lactones was quite variable. Accordingly, depending on the product, the total daily intake of lactones varied from 56 to 312 mg. Concerning speed, selectivity, and environmental friendly operation, this supercritical fluid chromatography approach surpasses all previously reported ones.

* Dedicated to Professor Dr. Max Wichtl in recognition of his outstanding contribution to pharmacognosy research.


Supporting Information

A comparison of the UV spectra of six kavalactone standards and respective signals in a sample solution is available as Supporting Information.

 
  • References

  • 1 Singh YN. Kava: an overview. J Ethnopharmacol 1992; 37: 13-45
  • 2 Ma Y, Sachdeva KL, Lui J, Ford M, Yang D, Khan IA, Chichester CO, Yan B. Desmethoxyyangonin and dihydromethysticin are two major kavalactones with marked activity on the induction of CYP3A23. Drug Metab Dispos 2004; 32: 1317-1324
  • 3 Kuchta K, Schmidt M, Nahrstedt A. German kava ban lifted by court: the alleged hepatotoxicity of kava (Piper methysticum) as a case of ill-defined herbal drug identity, lacking quality control, and misguided regulatory politics. Planta Med 2015; 81: 1647-1653
  • 4 Sarris J, Scholey A, Schweitzer I, Bousman C, LaPorte E, Ng C, Murray G, Stough C. The acute effects of kava and oxacepam on anxiety, mood, neurocognition and genetic correlates: a randomized, placebo-controlled, double-blind study. Hum Psychopharmacol 2012; 27: 262-269
  • 5 Garrett KM, Basmadjian G, Khan IA, Schaneberg BT, Searle TW. Extracts of kava (Piper methysticum) induce acute anxiolytic-like behavioral changes in mice. Psychopharmacology (Berl) 2003; 170: 33-41
  • 6 Gastpar M, Klimm HD. Treatment of anxiety, tension and restlessness states with kava special extract WS 1490 in general practice; a randomized placebo-controlled double-blind multicenter trial. Phytomedicine 2003; 10: 631-639
  • 7 Tang SN, Zhang J, Jiang P, Datta P, Leitzman P, OʼSullivan MG, Jiang C, Xing C, Lue J. Gene expression signatures associated with suppression of TRAMP prostate carcinogenesis by a kavalactone-rich kava fraction. Mol Carcinog 2016; 55: 2291-2303
  • 8 Narayanapillai SC, Balbo S, Leitzmann P, Grill AE, Upadhyaya P, Shaik AA, Zhou B, OʼSullivan MG, Peterson LA, Lu J, Hecht SS, Xing C. Dihydromethysticin from kava blocks tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis and differentially reduces DNA damage in A/J mice. Carcinogenesis 2014; 35: 2365-2372
  • 9 Abdel Jaleel GA, Saleh DO, El-Awdan SA. Antihyperglycaemic effect of kava-kava (Piper methysticum) in streptozotocin-induced diabetic rats. Pharm Lett 2013; 5: 104-110
  • 10 Ganzera M, Khan IA. Analytical techniques for the determination of lactones in Piper methysticum Forst. Chromatographia 1999; 50: 649-653
  • 11 Bilia AR, Scalise L, Bergonzi MC, Vincieri FF. Analysis of kavalactones from Piper methysticum (kava-kava). J Chromatogr B 2004; 812: 203-214
  • 12 Lebot V, Legendre L. Comparison of kava (Piper methysticum Forst.) varieties by UV absorbance of acetonic extracts and high-performance thin-layer chromatography. J Food Compos Anal 2016; 48: 25-33
  • 13 Mathon C, Duret M, Kohler M, Edder P, Bieri S, Christen P. Multi-targeted screening of botanicals in food supplements by liquid chromatography with tandem mass spectrometry. Food Chem 2013; 138: 709-717
  • 14 Lasme P, Davrieux F, Montet D, Lebot V. Quantification of kavalactones and determination of kava (Piper methysticum) chemotypes using near-infrared reflectance spectroscopy for quality control in Vanuatu. J Agric Food Chem 2008; 56: 4976-4981
  • 15 Lopez-Avila V, Benedicto J. Supercritical fluid extraction of kava lactones from Piper methysticum (kava) herb. J High Resolut Chrom 1997; 20: 555-559
  • 16 Ashraf-Khorassani M, Taylor LT, Martin M. Supercritical fluid extraction of kava lactones from kava root and their separation via supercritical fluid chromatography. Chromatographia 1999; 50: 287-292
  • 17 Hartmann A, Ganzera M. Supercritical fluid chromatography – theoretical background and applications on natural products. Planta Med 2015; 81: 1570-1581
  • 18 Pfeifer I, Murauer A, Ganzera M. Determination of coumarins in the roots of Angelica dahurica by supercritical fluid chromatography. J Pharmaceut Biomed 2016; 129: 246-251
  • 19 Aichner D, Ganzera M. Analysis anthraquinones in rhubarb (Rheum palmatum and Rheum officinale) by supercritical fluid chromatography. Talanta 2015; 144: 1239-1244
  • 20 International Conference on Harmonization of technical Requirements for the Registration of Pharmaceuticals for Human Use – Validation of analytical Procedures Q2(R1). Available at http://www.ich.org Accessed December 19, 2016